Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
1,150
1,100
1,049
1,003
931
818
Crecimiento de los Ingresos (YoY)
-16%
5%
5%
8%
14%
5%
Costo de los ingresos
506
498
472
446
412
374
Utilidad bruta
643
602
577
557
518
443
Venta, General y Administración
257
242
236
245
198
178
Investigación y Desarrollo
--
--
--
--
--
--
Gastos de Operación
300
304
300
308
261
237
Otras Ingresos (Gastos) No Operativos
7
5
7
6
15
9
Ingreso antes de impuestos
121
113
106
-243
175
-38
Gasto por Impuesto a la Renta
66
69
54
-9
58
-1
Ingreso Neto
55
44
51
-233
115
-38
Crecimiento de la Utilidad Neta
-28%
-14%
-122%
-303%
-403%
90%
Acciones en Circulación (Diluidas)
286.74
284.9
283.22
280.1
279.4
286
Cambio de Acciones (YoY)
0%
1%
1%
0%
-2%
3%
EPS (Diluido)
0.19
0.15
0.18
-0.83
0.41
-0.14
Crecimiento de EPS
-28.99%
-14%
-122%
-302%
-393%
75%
Flujo de efectivo libre
86
45
-362
95
179
67
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
55.91%
54.72%
55%
55.53%
55.63%
54.15%
Margen de operación
29.82%
27%
26.31%
24.72%
27.49%
25.18%
Margen de beneficio
4.78%
4%
4.86%
-23.23%
12.35%
-4.64%
Margen de flujo de caja libre
7.47%
4.09%
-34.5%
9.47%
19.22%
8.19%
EBITDA
487
460
433
393
406
349
Margen de EBITDA
42.34%
41.81%
41.27%
39.18%
43.6%
42.66%
D&A para EBITDA
144
163
157
145
150
143
EBIT
343
297
276
248
256
206
Margen de EBIT
29.82%
27%
26.31%
24.72%
27.49%
25.18%
Tasa de Impuesto Efectiva
54.54%
61.06%
50.94%
3.7%
33.14%
2.63%
Estadísticas clave
Cierre Anterior
$16.97
Precio de apertura
$16.99
Rango del día
$16.72 - $17.43
Rango de 52 semanas
$9.53 - $19.85
Volumen
1.5M
Volumen promedio
2.0M
EPS (TTM)
0.19
Rendimiento de dividendos
--
Cap. de mercado
$4.8B
¿Qué es SHC?
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.